RxDoctor Payments DataLook up a doctor →

Jared Thorley, APRN

Family · Salt Lake City, UTNPI 1093065385

Payments from drug & device makers

$368,189in general payments, 2019–2025

Across 960 payments — averaging $383.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Eisai Inc.$163K
  • Exelixis Inc.$118K
  • Johnson & Johnson$56K
  • Pfizer$12K
  • Merck$8K
  • E.r. Squibb & Sons, L.L.C.$6K
  • plus $5K from 7 others
$4,470in research payments, 2019–2025

Across 3 payments — averaging $1490.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Pfizer$4K

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$368,189 in reported general payments places this provider in the 95th percentile of 1,460 family providers in Utah.

See all family providers in Utah

Medicare billing

Part B allowed, 2024
$80,092
Medicare patients
120
Services billed
765

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family in Salt Lake City

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →